The Assessment of the Relationship Between Genetic Determinants of Migraine and Thyroid Dysfunction - Review
DOI:
https://doi.org/10.12775/JEHS.2024.59.001Keywords
Migraine, Thyroid dysfunction, Hypothyroidism, Genetics, candidate gene studies, epidemiological studiesAbstract
Introduction and objective: The purpose of this paper is a systematic review of articles and research in the context of the relationship between genetic determinants of migraine and thyroid dysfunction.
Materials and methods: A non-systematic review of the scientific literature was carried out according to the following keywords: PubMed was searched and 76 articles published up to 2023 were analyzed.
Description of the state of knowledge: Epidemiological studies confirm the co-occurrence of migraine and thyroid dysfunction, especially hypothyroidism, which are considered to be diseases with a strong genetic background. Thyroid function parameters such as TSH and fT4 are susceptible to genetic influences. However, there is a lack of consistent interpretation of the observational results, which highlights the need for further research. Analysis of gene overlaps and links between headache and thyroid function, based on GWAS data, could shed light on the complex genetic interactions underlying this association.
Summary: The genetic associations revealed in the study enhance our comprehension of the intricate relationship between migraine and thyroid dysfunction. These findings not only offer the prospect of developing biomarkers for identifying migraine patients who might benefit from thyroid hormone therapy but also underscore the promising potential of future genetic studies in providing biological insights to advance clinical decision-making in understanding and addressing these interconnected phenomena.
References
Tasnim S, Nyholt DR. Migraine and thyroid dysfunction: Co-occurrence, shared genes and biological mechanisms. Eur J Neurol. 2023 Jun;30(6):1815-1827. doi: 10.1111/ene.15753. Epub 2023 Mar 9. PMID: 36807966.
Tasnim S, Wilson SG, Walsh JP, Nyholt DR; International Headache Genetics Consortium (IHGC). Shared genetics and causal relationships between migraine and thyroid function traits. Cephalalgia. 2023 Feb;43(2):3331024221139253. doi: 10.1177/03331024221139253. PMID: 36739509.
Tasnim S, Wilson SG, Walsh JP, Nyholt DR. Cross-Trait Genetic Analyses Indicate Pleiotropy and Complex Causal Relationships between Headache and Thyroid Function Traits. Genes (Basel). 2022 Dec 21;14(1):16. doi: 10.3390/genes14010016. PMID: 36672757; PMCID: PMC9858525.
Spanou I, Bougea A, Liakakis G, Rizonaki K, Anagnostou E, Duntas L, Kararizou E. Relationship of Migraine and Tension-Type Headache With Hypothyroidism: A Literature Review. Headache. 2019 Sep;59(8):1174-1186. doi: 10.1111/head.13600. Epub 2019 Jul 16. PMID: 31310335.
Aguilar-Shea AL, Membrilla Md JA, Diaz-de-Teran J. Migraine review for general practice. Aten Primaria. 2022 Feb;54(2):102208. doi: 10.1016/j.aprim.2021.102208. Epub 2021 Nov 16. PMID: 34798397; PMCID: PMC8605054.
Dodick DW. A Phase-by-Phase Review of Migraine Pathophysiology. Headache. 2018 May;58 Suppl 1:4-16. doi: 10.1111/head.13300. PMID: 29697154.
Lampl C, Thomas H, Stovner LJ, Tassorelli C, Katsarava Z, Laínez JM, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Andrée C, Steiner TJ. Interictal burden attributable to episodic headache: findings from the Eurolight project. J Headache Pain. 2016;17:9. doi: 10.1186/s10194-016-0599-8. Epub 2016 Feb 16. PMID: 26879832; PMCID: PMC4754227.
Lipton RB, Dodick DW, Ailani J, McGill L, Hirman J, Cady R. Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome. Headache. 2021 May;61(5):766-776. doi: 10.1111/head.14120. Epub 2021 May 20. PMID: 34013992; PMCID: PMC8251621.
Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol. 2018 Dec;14(12):699-710. doi: 10.1038/s41582-018-0098-4. PMID: 30448858.
Puledda F, Silva EM, Suwanlaong K, Goadsby PJ. Migraine: from pathophysiology to treatment. J Neurol. 2023 Jul;270(7):3654-3666. doi: 10.1007/s00415-023-11706-1. Epub 2023 Apr 8. PMID: 37029836; PMCID: PMC10267278.
Macvanin MT, Gluvic ZM, Zaric BL, Essack M, Gao X, Isenovic ER. New biomarkers: prospect for diagnosis and monitoring of thyroid disease. Front Endocrinol (Lausanne). 2023 Jul 21;14:1218320. doi: 10.3389/fendo.2023.1218320. PMID: 37547301; PMCID: PMC10401601.
Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017 Sep 23;390(10101):1550-1562. doi: 10.1016/S0140-6736(17)30703-1. Epub 2017 Mar 20. PMID: 28336049; PMCID: PMC6619426.
Chiovato L, Magri F, Carlé A. Hypothyroidism in Context: Where We've Been and Where We're Going. Adv Ther. 2019 Sep;36(Suppl 2):47-58. doi: 10.1007/s12325-019-01080-8. Epub 2019 Sep 4. PMID: 31485975; PMCID: PMC6822815.
Fuentes AV, Pineda MD, Venkata KCN. Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice. Pharmacy (Basel). 2018 May 14;6(2):43. doi: 10.3390/pharmacy6020043. PMID: 29757930; PMCID: PMC6025009.
Zhu Y, Zhang J, Wang C, Zheng T, Di S, Wang Y, Fei W, Liang W, Wang L. Ameliorative Effect of Ethanolic Echinacea purpurea against Hyperthyroidism-Induced Oxidative Stress via AMRK and PPAR Signal Pathway Using Transcriptomics and Network Pharmacology Analysis. Int J Mol Sci. 2022 Dec 22;24(1):187. doi: 10.3390/ijms24010187. PMID: 36613632; PMCID: PMC9820381.
Wang C, Li Y, Teng D, Shi X, Ba J, Chen B, Du J, He L, Lai X, Li Y, Chi H, Liao E, Liu C, Liu L, Qin G, Qin Y, Quan H, Shi B, Sun H, Tang X, Tong N, Wang G, Zhang JA, Wang Y, Xue Y, Yan L, Yang J, Yang L, Yao Y, Ye Z, Zhang Q, Zhang L, Zhu J, Zhu M, Shan Z, Teng W. Hyperthyroidism Prevalence in China After Universal Salt Iodization. Front Endocrinol (Lausanne). 2021 May 28;12:651534. doi: 10.3389/fendo.2021.651534. PMID: 34122333; PMCID: PMC8194401.
Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014 Mar;99(3):923-31. doi: 10.1210/jc.2013-2409. Epub 2014 Jan 1. PMID: 24423323.
Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb;87(2):489-99. doi: 10.1210/jcem.87.2.8182. PMID: 11836274.
Ane Garmendia Madariaga, Silvia Santos Palacios, Francisco Guillén-Grima, Juan C. Galofré, The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-Analysis, The Journal of Clinical Endocrinology & Metabolism, Volume 99, Issue 3, 1 March 2014, Pages 923–931, https://doi.org/10.1210/jc.2013-2409
Jansen HI, Boelen A, Heijboer AC, Bruinstroop E, Fliers E. Hypothyroidism: The difficulty in attributing symptoms to their underlying cause. Front Endocrinol (Lausanne). 2023 Feb 6;14:1130661. doi: 10.3389/fendo.2023.1130661. PMID: 36814580; PMCID: PMC9939761.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM; American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014 Dec;24(12):1670-751. doi: 10.1089/thy.2014.0028. PMID: 25266247; PMCID: PMC4267409.
Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012 Mar 24;379(9821):1142-54. doi: 10.1016/S0140-6736(11)60276-6. Epub 2012 Jan 23. PMID: 22273398.
Ashina M, Terwindt GM, Al-Karagholi MA, de Boer I, Lee MJ, Hay DL, Schulte LH, Hadjikhani N, Sinclair AJ, Ashina H, Schwedt TJ, Goadsby PJ. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021 Apr 17;397(10283):1496-1504. doi: 10.1016/S0140-6736(20)32162-0. Epub 2021 Mar 25. PMID: 33773610.
GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14. PMID: 30879893; PMCID: PMC6459001.
GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):954-976. doi: 10.1016/S1474-4422(18)30322-3. Erratum in: Lancet Neurol. 2021 Dec;20(12):e7. PMID: 30353868; PMCID: PMC6191530.
Hovaguimian A, Roth J. Management of chronic migraine. BMJ. 2022 Oct 10;379:e067670. doi: 10.1136/bmj-2021-067670. PMID: 36216384.
Khan J, Asoom LIA, Sunni AA, Rafique N, Latif R, Saif SA, Almandil NB, Almohazey D, AbdulAzeez S, Borgio JF. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother. 2021 Jul;139:111557. doi: 10.1016/j.biopha.2021.111557. Epub 2021 May 17. PMID: 34243621.
Tepper SJ, Dahlöf CG, Dowson A, Newman L, Mansbach H, Jones M, Pham B, Webster C, Salonen R. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache. 2004 Oct;44(9):856-64. doi: 10.1111/j.1526-4610.2004.04167.x. PMID: 15447694.
Kernick D, Stapley S, Campbell J, Hamilton W. What happens to new-onset headache in children that present to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2009 Dec;29(12):1311-6. doi: 10.1111/j.1468-2982.2009.01872.x. PMID: 19911465.
Stone J, Carson A, Duncan R, Roberts R, Warlow C, Hibberd C, Coleman R, Cull R, Murray G, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Smyth R, Walker J, Sharpe M. Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg. 2010 Nov;112(9):747-51. doi: 10.1016/j.clineuro.2010.05.011. Epub 2010 Jun 19. PMID: 20646830.
Shankar Kikkeri N, Nagalli S. Migraine With Aura. 2022 Dec 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 32119498.
Riederer F, Beiersdorf J, Scutelnic A, Schankin CJ. Migraine Aura-Catch Me If You Can with EEG and MRI-A Narrative Review. Diagnostics (Basel). 2023 Sep 2;13(17):2844. doi: 10.3390/diagnostics13172844. PMID: 37685382; PMCID: PMC10486733.
Karsan N, Silva E, Goadsby PJ. Evaluating migraine with typical aura with neuroimaging. Front Hum Neurosci. 2023 Mar 21;17:1112790. doi: 10.3389/fnhum.2023.1112790. PMID: 37025972; PMCID: PMC10070832.
Lemale CL, Lückl J, Horst V, Reiffurth C, Major S, Hecht N, Woitzik J, Dreier JP. Migraine Aura, Transient Ischemic Attacks, Stroke, and Dying of the Brain Share the Same Key Pathophysiological Process in Neurons Driven by Gibbs-Donnan Forces, Namely Spreading Depolarization. Front Cell Neurosci. 2022 Feb 10;16:837650. doi: 10.3389/fncel.2022.837650. Erratum in: Front Cell Neurosci. 2022 Apr 26;16:917669. PMID: 35237133; PMCID: PMC8884062.
Grangeon L, Lange KS, Waliszewska-Prosół M, Onan D, Marschollek K, Wiels W, Mikulenka P, Farham F, Gollion C, Ducros A; European Headache Federation School of Advanced Studies (EHF-SAS). Genetics of migraine: where are we now? J Headache Pain. 2023 Feb 20;24(1):12. doi: 10.1186/s10194-023-01547-8. PMID: 36800925; PMCID: PMC9940421.
Jiang Z, Zhao L, Zhang X, Zhang W, Feng Y, Li T. Common variants in KCNK5 and FHL5 genes contributed to the susceptibility of migraine without aura in Han Chinese population. Sci Rep. 2021 Mar 24;11(1):6807. doi: 10.1038/s41598-021-86374-0. PMID: 33762637; PMCID: PMC7990926.
Tsai CK, Liang CS, Lin GY, Tsai CL, Lee JT, Sung YF, Lin YK, Hung KS, Chen WL, Yang FC. Identifying genetic variants for age of migraine onset in a Han Chinese population in Taiwan. J Headache Pain. 2021 Aug 11;22(1):89. doi: 10.1186/s10194-021-01301-y. PMID: 34380431; PMCID: PMC8356430.
Cader MZ. The genetics of migraine and the path to precision medicine. Prog Brain Res. 2020;255:403-418. doi: 10.1016/bs.pbr.2020.06.008. Epub 2020 Aug 25. PMID: 33008515.
Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011 May;10(5):457-70. doi: 10.1016/S1474-4422(11)70048-5. Epub 2011 Mar 30. PMID: 21458376.
Rovet JF. The role of thyroid hormones for brain development and cognitive function. Endocr Dev. 2014;26:26-43. doi: 10.1159/000363153. Epub 2014 Aug 29. PMID: 25231442.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000 Feb 28;160(4):526-34. doi: 10.1001/archinte.160.4.526. PMID: 10695693.
Tuchendler D, Bolanowski M. The influence of thyroid dysfunction on bone metabolism. Thyroid Res. 2014 Dec 20;7(1):12. doi: 10.1186/s13044-014-0012-0. PMID: 25648501; PMCID: PMC4314789.
Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, Munafò MR. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013 May;14(5):365-76. doi: 10.1038/nrn3475. Epub 2013 Apr 10. Erratum in: Nat Rev Neurosci. 2013 Jun;14(6):451. PMID: 23571845.
Schürks M, Kurth T, Buring JE, Zee RY. A candidate gene association study of 77 polymorphisms in migraine. J Pain. 2009;10(7):759-766. doi:10.1016/j.jpain.2009.01.326
Stanilova SA, Gerenova JB, Miteva LD, Manolova IM. The role of transforming growth factor-β1 gene polymorphism and its serum levels in Hashimoto's thyroiditis. Curr Pharm Biotechnol. 2018;19(7):581-589. doi:10.2174/1389201019666180802142803
Nanba T, Watanabe M, Akamizu T, Iwatani Y. The −590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin Chem. 2008;54(3):621-623. doi:10.1373/clinchem.2007.099739
Rubino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia. 2009;29(8):818-825. doi:10.1111/j.1468-2982.2007.01400.x
Schurks M, Rist PM, Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache. 2010;50(4):588-599. doi:10.1111/j.1526-4610.2009.01570.x
Abu-Hassan DW, Alhouri AN, Altork NA, et al. MTHFR gene polymorphisms in hypothyroidism and hyperthyroidism among Jordanian females. Arch Endocrinol Metab. 2019;63(3):280-287. doi:10.20945/2359-3997000000133
Abu-Hassan DW, Alhouri AN, Altork NA, et al. MTHFR gene polymorphisms in hypothyroidism and hyperthyroidism among Jordanian females. Arch Endocrinol Metab. 2019;63(3):280-287. doi:10.20945/2359-3997000000133
Liu R, Geng P, Ma M, et al. MTHFR C677T polymorphism and migraine risk: a meta-analysis. J Neurol Sci. 2014;336(1):68-73. doi:10.1016/j.jns.2013.10.008
Teumer A, Chaker L, Groeneweg S, et al. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation. Nat Commun. 2018;9(1):4455. doi:10.1038/s41467-018-06356-1
Reddy N, Desai MN, Schoenbrunner A, Schneeberger S, Janis JE. The complex relationship between estrogen and migraines: a scoping review. Syst Rev. 2021;10(1):72. doi:10.1186/s13643-021-01618-4
Gietka-Czernel M. The thyroid gland in postmenopausal women: physiology and diseases. Prz Menopauzalny. 2017;16(2):33-37. doi:10.5114/pm.2017.68588
Decaroli MC, Rochira V. Aging and sex hormones in males. Virulence. 2017;8(5):545-570. doi:10.1080/21505594.2016.1259053
Greer JM, Broadley S, Pender MP. Reactivity to novel autoantigens in patients with coexisting central nervous system demyelinating disease and autoimmune thyroid disease. Front Immunol. 2017;8:514. doi:10.3389/fimmu.2017.00514
Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies-successful translation from bench to clinic. Nat Rev Neurol. 2018;14(6):338-350. doi:10.1038/s41582-018-0003-1
Deen M, Correnti E, Kamm K, et al. Blocking CGRP in migraine patients-a review of pros and cons. J Headache Pain. 2017;18(1):96. doi:10.1186/s10194-017-0807-1
Jacqies-Jean B, Demesster-Mirkine N, Borkowski A, Suciu S, Corvilain J. Calcitonin deficiency in primary hypothyroidism*. J Clin Endocrinol Metab. 1986;62(4):700-703. doi:10.1210/jcem-62-4-700
Hargreaves R, Olesen J. Calcitonin gene-related peptide modulators-the history and renaissance of a new migraine drug class. Headache. 2019;59(6):951-970. doi:10.1111/head.13510
Filipchuk M, Gassmann J, Castro Zamparella T, et al. High rates of (treated) hypothyroidism among chronic migraine patients consulting a specialized headache clinic: are we missing something? Neurol Sci. 2022;43(2):1249-1254. doi:10.1007/s10072-021-05424-7
Le H, Tfelt-Hansen P, Russell MB, Skytthe A, Kyvik KO, Olesen J. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia. 2011 Jan;31(1):43-64. doi: 10.1177/0333102410373159. Epub 2010 Jun 2. PMID: 20974590.
Martin AT, Pinney SM, Xie C, Herrick RL, Bai Y, Buckholz J, Martin VT. Headache Disorders May Be a Risk Factor for the Development of New Onset Hypothyroidism. Headache. 2017 Jan;57(1):21-30. doi: 10.1111/head.12943. Epub 2016 Sep 27. PMID: 27676320; PMCID: PMC8805018.
Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Recent Advances in Thyroid Hormone Regulation: Toward a New Paradigm for Optimal Diagnosis and Treatment. Front Endocrinol (Lausanne). 2017 Dec 22;8:364. doi: 10.3389/fendo.2017.00364. PMID: 29375474; PMCID: PMC5763098.
Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Recent Advances in Thyroid Hormone Regulation: Toward a New Paradigm for Optimal Diagnosis and Treatment. Front Endocrinol (Lausanne). 2017 Dec 22;8:364. doi: 10.3389/fendo.2017.00364. PMID: 29375474; PMCID: PMC5763098.
Lewis R, Ruiz A, Monteith T. Reversible Lesion of the Corpus Callosum in a Patient With Migraine With Aura: A Case Study. Headache. 2020 Apr;60(4):791-792. doi: 10.1111/head.13768. Epub 2020 Feb 11. PMID: 32048282.
Namatame C, Sonoo T, Fukushima K, Naraba H, Hashimoto H, Nakamura K. A thyroid storm patient with protracted disturbance of consciousness and reversible lesion in the splenium of corpus callosum: A case report. Medicine (Baltimore). 2018 Feb;97(7):e9949. doi: 10.1097/MD.0000000000009949. PMID: 29443784; PMCID: PMC5839822.
Nagel M, Jansen PR, Stringer S, Watanabe K, de Leeuw CA, Bryois J, Savage JE, Hammerschlag AR, Skene NG, Muñoz-Manchado AB; 23andMe Research Team; White T, Tiemeier H, Linnarsson S, Hjerling-Leffler J, Polderman TJC, Sullivan PF, van der Sluis S, Posthuma D. Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways. Nat Genet. 2018 Jul;50(7):920-927. doi: 10.1038/s41588-018-0151-7. Epub 2018 Jun 25. PMID: 29942085.
Tsao YC, Wang SJ, Hsu CL, Wang YF, Fuh JL, Chen SP, Fann CS. Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population. Cephalalgia. 2022 Mar;42(3):229-238. doi: 10.1177/03331024211037269. Epub 2021 Aug 18. PMID: 34404248.
Law C, Bunyan D, Castle B, Day L, Simpson I, Westwood G, Keeton B. Clinical features in a family with an R460H mutation in transforming growth factor beta receptor 2 gene. J Med Genet. 2006 Dec;43(12):908-16. doi: 10.1136/jmg.2006.042176. Epub 2006 Aug 2. PMID: 16885183; PMCID: PMC2563201.
Stankewitz A, Keidel L, Rehm M, Irving S, Kaczmarz S, Preibisch C, Witkovsky V, Zimmer C, Schulz E, Toelle TR. Migraine attacks as a result of hypothalamic loss of control. Neuroimage Clin. 2021;32:102784. doi: 10.1016/j.nicl.2021.102784. Epub 2021 Aug 16. PMID: 34425551; PMCID: PMC8379646.
Bhattacharjee M, Karim MR, Rahman MA, Mondol G, Khan MK, Biswas R, Sarker UK. Association of Low Thyroid Hormone with Migraine Headache. Mymensingh Med J. 2021 Jan;30(1):43-47. PMID: 33397849.
May A, Burstein R. Hypothalamic regulation of headache and migraine. Cephalalgia. 2019 Nov;39(13):1710-1719. doi: 10.1177/0333102419867280. Epub 2019 Aug 29. PMID: 31466456; PMCID: PMC7164212.
May A, Burstein R. Hypothalamic regulation of headache and migraine. Cephalalgia. 2019 Nov;39(13):1710-1719. doi: 10.1177/0333102419867280. Epub 2019 Aug 29. PMID: 31466456; PMCID: PMC7164212.
Jerzmanowski A, Klimek A. Immunoglobulins and complement in migraine. Cephalalgia. 1983 Jun;3(2):119-23. doi: 10.1046/j.1468-2982.1983.0302119.x. PMID: 6871986.
Beck-Peccoz P, Rodari G, Giavoli C, Lania A. Central hypothyroidism - a neglected thyroid disorder. Nat Rev Endocrinol. 2017 Oct;13(10):588-598. doi: 10.1038/nrendo.2017.47. Epub 2017 May 26. PMID: 28549061.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Justyna Kwiecień, Beata Getka, Michał Łata, Kinga Przyborowska, Katarzyna Wiejak, Mateusz Rukat
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 314
Number of citations: 0
